FDA 483 OBSERVATION · #946 OF 1,932 MOST-CITED
Completion of eligibility determination
FDA cited this observation 19 times across 18 firms in recent inspections. Below: how it breaks down by program area and fiscal year, and real examples of how FDA worded it on Form FDA 483.
What this grouping is not
An observation-type page groups FDA’s published citation records. The grouping, the compliance steps and the root causes are SPEQ synthesis, not an FDA classification of any citation, and a count measures what FDA published rather than risk.
How FDA worded it — real examples
HCT/Ps were not kept in quarantine until completion of the donor-eligibility determination.
HCT/Ps were not kept in quarantine until completion of the donor-eligibility determination.
HCT/Ps were not kept in quarantine until completion of the donor-eligibility determination.
HCT/Ps were not kept in quarantine until completion of the donor-eligibility determination.
HCT/Ps were not kept in quarantine until completion of the donor-eligibility determination.
HCT/Ps were not kept in quarantine until completion of the donor-eligibility determination.
Examples are a representative sample of FDA's published inspection observations. Open the 483 observation explorer →